一个全面的工程策略可以提高抗艾滋病毒近全中和抗体的效力和可制造性

Mohammad M Sajadi1, Abdolrahim Abbasi2, Zahra Rikhtegaran Tehrani2

  • 1Divisions of Vaccine Research and Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA; Department of Medicine, Maryland VA Healthcare System, Baltimore, MD, USA.

概括

针对艾滋病毒的工程广泛中和抗体 (bnAbs) 显示出增强的功效和更长的半衰期. 这些进展为改进的艾滋病毒预防和治疗策略以及更好的制造能力铺平了道路.